METTL3 inhibition or knockout affects tumor cell proliferation and tumor growth, with YTHDF2 playing a key role and enhancing antitumor effects in a T-cell-dependent manner, indicating that YTHDF2 is a downstream executor of STM2457’s antitumor effects (107). The gene discussed is YTHDF2; the disease is neoplasm.